In yesterday’s Wall Street session, Navidea Biopharmaceuticals Inc. (AMEX:NAVB) shares traded at $0.12, down -1.67% from the previous session.
1 analysts cover Navidea Biopharmaceuticals Inc. (AMEX:NAVB), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a low of $8.00, we find $8.00. Given the previous closing price of $0.12, this indicates a potential upside of 6566.67 percent. NAVB stock price is now 10.88% away from the 50-day moving average and -48.07% away from the 200-day moving average. The market capitalization of the company currently stands at $11.59M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The stock has received a hold rating from 0 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $8.00 as their price target over the next twelve months.
With the price target reduced from $3 to $2, Aegis Capital maintained Hold rating for Navidea Biopharmaceuticals Inc. (AMEX: NAVB).
A total of 26.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NAVB stock. A new stake in Navidea Biopharmaceuticals Inc. shares was purchased by MILLENNIUM MANAGEMENT LLC during the first quarter worth $15,000. In the first quarter, ROYAL BANK OF CANADA acquired a new stake in Navidea Biopharmaceuticals Inc. valued at approximately,000. In total, there are 30 active investors with 4.70% ownership of the company’s stock.
On Wednesday morning Navidea Biopharmaceuticals Inc. (AMEX: NAVB) stock kicked off with the opening price of $0.1200. During the past 12 months, Navidea Biopharmaceuticals Inc. has had a low of $0.07 and a high of $0.71. The fifty day moving average price for NAVB is $0.1054 and a two-hundred day moving average price translates $0.2269 for the stock.
The latest earnings results from Navidea Biopharmaceuticals Inc. (AMEX: NAVB) was released for Mar, 2023.
